Yi Yu, Junhe Li, Wei Gan, Jun Chen, Laixiang Li. "Real-world study of anti–PD-1 combined with regorafenib and raltitrexed as third-line therapy in colorectal cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15510